We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Takes Risk-Management Approach to Initial Human Trials in Revised Guidelines
EMA Takes Risk-Management Approach to Initial Human Trials in Revised Guidelines
The EMA is revising nearly decade-old guidelines on first-in-human trials after a patient died in a French study earlier this year to offer drugmakers guidance on risk management.